The text starts here.

News Release

Information in the news releases is current on the date of the announcement, but is subject to change without prior notice.

1999 Release

November 19, 1999 ARICEPT, an Alzheimer's Disease Treatment, to be Launched in Japan
November 8, 1999 Eisai Launches SACLON S & SACLON S Tablets -Refreshing Relief From Upset Stomach-
November 4, 1999 Eisai Co., Ltd. Reaches Vitamin Settlement with U.S. Civil Plaintiffs
October 12, 1999 ARICEPT, An Alzheimer's Disease Treatment, Receives Production Approval in Japan
September 10, 1999 Eisai Co., Ltd. Reaches Vitamin Settlement
September 10, 1999 Synthetic Vitamin E Settlement in the U.S. and Business Results Forecast Revision
September 1, 1999 Reformulated SAHNE CREAM and SAHNE SKIN MILK in Redesigned Packaging Launched by EISAI
August 30, 1999 PARIET, a Proton Pump Inhibitor, Receives Marketing Approval in The EU for Gord Maintenance Therapy
August 20, 1999 Eisai's U.S. Subsidiary Receives FDA Marketing Clearance for ACIPHEX a Proton Pump Inhibitor
June 21, 1999 Eisai and BASF Pharma Announce Agreement to Co-Develop Knoll's new Anti-Rheumatic in Japan
May 21, 1999 Eisai Announces Non-Consolidated and Consolidated Financial Results for the Fiscal Year Ended March 31, 1999
May 17, 1999 Eisai Launches Sea-Bond A Sheet-Type Denture Adhesive
April 21, 1999 Novo Nordisk Pharma Ltd. and Eisai Co., Ltd. Announced Distribution & Promotion Agreement for Glucagon G Novo
April 12, 1999 Tokyo District Court Orders a Prohibitory Injunction Requiring Suspension of Production and Sales Concerning the Patent Infringement of the "Eitest PIVKA-II" Patent
March 2, 1999 Eisai's Kawashima Industrial Park Receives ISO 14001 Certification

Back to Top